Search by Drug Name or NDC
NDC 44087-3344-01 REBIF REBIDOSE 44 ug/.5mL Details
REBIF REBIDOSE 44 ug/.5mL
REBIF REBIDOSE is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by EMD Serono, Inc.. The primary component is INTERFERON BETA-1A.
MedlinePlus Drug Summary
Interferon beta-1a intramuscular injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Related Packages: 44087-3344-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Interferon Beta-1a Intramuscular Injection
Interferon beta-1a subcutaneous injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Related Packages: 44087-3344-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Interferon Beta-1a Subcutaneous Injection
Product Information
| NDC | 44087-3344 |
|---|---|
| Product ID | 44087-3344_348c7db6-5713-4329-83ca-14925b9b1d69 |
| Associated GPIs | 6240306045D540 |
| GCN Sequence Number | 070588 |
| GCN Sequence Number Description | interferon beta-1a/albumin PEN INJCTR 44MCG/.5ML SUBCUT |
| HIC3 | H0E |
| HIC3 Description | AGENTS TO TREAT MULTIPLE SCLEROSIS |
| GCN | 34168 |
| HICL Sequence Number | 023353 |
| HICL Sequence Number Description | INTERFERON BETA-1A/ALBUMIN HUMAN |
| Brand/Generic | Brand |
| Proprietary Name | REBIF REBIDOSE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | INTERFERON BETA-1A |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 44 |
| Active Ingredient Units | ug/.5mL |
| Substance Name | INTERFERON BETA-1A |
| Labeler Name | EMD Serono, Inc. |
| Pharmaceutical Class | Interferon beta [EPC], Interferon-beta [CS] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA103780 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 44087-3344-01 (44087334401)
| NDC Package Code | 44087-3344-1 |
|---|---|
| Billing NDC | 44087334401 |
| Package | 12 PACKAGE in 1 CARTON (44087-3344-1) / .5 mL in 1 PACKAGE (44087-3344-9) |
| Marketing Start Date | 2012-12-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |